Neonatal hemolytic uremic syndrome after mother-to-child transmission of a low-pathogenic stx2b harboring shiga toxin-producing Escherichia coli

Clin Infect Dis. 2013 Jan;56(1):114-6. doi: 10.1093/cid/cis851. Epub 2012 Oct 5.

Abstract

This case describes evidence for a Shiga toxin-producing Escherichia coli (STEC) O146:H28 infection leading to hemolytic uremic syndrome in a neonate. STEC O146:H28 was linked hitherto with asymptomatic carriage in humans. Based on strain characteristics and genotyping data, the mother is a healthy carrier who transmitted the STEC during delivery. STEC strains belonging to the low-pathogenic STEC group must also be considered in the workup of neonatal hemolytic uremic syndrome.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticonvulsants / therapeutic use
  • Carrier State / microbiology
  • Escherichia coli Infections / microbiology
  • Escherichia coli Infections / transmission*
  • Feces / microbiology
  • Hemolytic-Uremic Syndrome / microbiology*
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical
  • Male
  • Seizures / diagnosis
  • Seizures / drug therapy
  • Shiga Toxin 2 / genetics
  • Shiga-Toxigenic Escherichia coli / genetics
  • Shiga-Toxigenic Escherichia coli / isolation & purification*
  • Shiga-Toxigenic Escherichia coli / pathogenicity

Substances

  • Anticonvulsants
  • Shiga Toxin 2
  • shiga toxin 2 B subunit